Pharmaceutical companies challenge the administration in court over negotiations by Medicare. White House Domestic Policy Council Director Neera Tanden expressed confidence in the legality of Medicare’s new program…
Read MorePharmaceuticals
Administration Announces Prescriptions Available for Price Negotiations
Ten drugs will be negotiated, with new pricing as of 2026. President Biden’s administration has announced the first 10 prescription drugs available for Medicare price negotiations. The pharmaceuticals…
Read More
Appeals Court Rules to Limit Access to Abortion Drug
Mifepristone was not ordered to be removed from the market, and the case goes to Supreme Court. The 5th Circuit Court of Appeals ruled that the Food and…
Read More
FDA and DEA Address Stimulant Medicine Shortage
Agency heads request an increase from manufacturers and for healthcare providers to slow demand. The Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) are taking steps…
Read More
FDA Approves 2nd Opioid Reversal Drug for Over-The-Counter Use
The nasal spray will be available prescription-free by next year. The Food and Drug Administration (FDA) recently approved the opioid overdose reversal drug RiVive for over-the-counter sale, making…
Read More
Federal Judge Allows Most Provisions of NC Abortion Ban
The only measure blocked by the court pertains to early pregnancy. District Judge Catherine Eagles ruled that most of North Carolina’s 12-week abortion law can go into effect…
Read More
DOJ Addresses Healthcare Fraud Across the Nation
Justice Department names 78 defendants in case of false billing to Medicare. The Department of Justice (DOJ) recently released dozens of federal and local criminal charges that address…
Read More
FTC Appeals Dismissal of Antitrust Case to 2nd Circuit
Maintains “pay-for-delay” practice by a pharmaceutical company violates antitrust law. The Federal Trade Commission (FTC) has appealed a federal district court’s dismissal of an antitrust case. The commission…
Read MoreFTC Expands Study into Prescription Drug Intermediaries
Group purchasing organizations are required to provide information on business practices. The Federal Trade Commission (FTC), as part of its ongoing study of pharmacy benefit managers (PBMs) and…
Read More
FDA Proposes Updates to Clinical Trials
The drafted guidance would modernize the trials to be more efficient and reliable. The U.S. Food and Drug Administration (FDA) has released a draft guidance that provides updated…
Read More